{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:46:37Z","timestamp":1776753997542,"version":"3.51.2"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04896-3","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:04:39Z","timestamp":1774699479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating autophagy and miRNAs as therapeutic targets in leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"Mutaz","family":"Jamal-Al-khreisat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"MazinBasheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Malathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Shankhyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashree","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8541-1037","authenticated-orcid":false,"given":"Mukhayya","family":"Ruzieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1716-2626","authenticated-orcid":false,"given":"Rasul","family":"Usmanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasan","family":"GhazanfarAhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"1","key":"4896_CR1","doi-asserted-by":"publisher","first-page":"2527015","DOI":"10.1080\/20565623.2025.2527015","volume":"11","author":"C Liang","year":"2025","unstructured":"Liang C, Lin JY, Liao LH, Song SY, Dai JT, Chen JJ, et al. Plasma metabolic landscape unveils key regulators of leukemia subtype progression. Future Sci OA. 2025;11 (1):2527015.","journal-title":"Future Sci OA"},{"key":"4896_CR2","doi-asserted-by":"publisher","first-page":"154285","DOI":"10.1016\/j.prp.2022.154285","volume":"242","author":"S Vedadi","year":"2023","unstructured":"Vedadi S, Azimzadeh M, Touluei AE, Rahimpour S, Shotorbani SS. The molecular and clinical significance of the Tie\/angiopoietin system in leukemia. Pathol Res Pract. 2023;242:154285.","journal-title":"Pathol Res Pract"},{"key":"4896_CR3","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.2147\/IJGM.S368364","volume":"15","author":"MA Assaye","year":"2022","unstructured":"Assaye MA, Gizaw ST. Chaperone-mediated autophagy and its implications for neurodegeneration and cancer. Int J Gen Med. 2022;15:5635\u201349.","journal-title":"Int J Gen Med"},{"issue":"1","key":"4896_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1272\/jnms.JNMS.2024_91-102","volume":"91","author":"H Yamamoto","year":"2024","unstructured":"Yamamoto H, Matsui T. Molecular mechanisms of macroautophagy, microautophagy, and chaperone-mediated autophagy. J Nippon Med Sch. 2024;91 (1):2\u20139.","journal-title":"J Nippon Med Sch"},{"issue":"7","key":"4896_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.tcb.2023.11.005","volume":"34","author":"Y Kuchitsu","year":"2024","unstructured":"Kuchitsu Y, Taguchi T. Lysosomal microautophagy: an emerging dimension in mammalian autophagy. Trends Cell Biol. 2024;34 (7):606\u201316.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4896_CR6","doi-asserted-by":"publisher","first-page":"1554469","DOI":"10.1080\/15592324.2018.1558679","volume":"14","author":"S Nakamura","year":"2019","unstructured":"Nakamura S, Izumi M. Chlorophagy is ATG gene-dependent microautophagy process. Plant Signal Behav. 2019;14 (1):1554469.","journal-title":"Plant Signal Behav"},{"key":"4896_CR7","first-page":"101986","volume":"42","author":"A Pandey","year":"2025","unstructured":"Pandey A, Goswami A, Jithin B, Shukla S. Autophagy: the convergence point of aging and cancer. Biochem Biophys Rep. 2025;42:101986.","journal-title":"Biochem Biophys Rep"},{"key":"4896_CR8","doi-asserted-by":"publisher","first-page":"145258","DOI":"10.1016\/j.gene.2020.145258","volume":"768","author":"T Demircan","year":"2021","unstructured":"Demircan T, Sibai M, Avsaroglu ME, Altuntas E, Ovezmyradov G. The first report on circulating microRNAs at Pre- and Post-metamorphic stages of axolotls. Gene. 2021;768:145258.","journal-title":"Gene"},{"issue":"8","key":"4896_CR9","doi-asserted-by":"publisher","first-page":"167984","DOI":"10.1016\/j.bbadis.2025.167984","volume":"1871","author":"O Wozniak","year":"2025","unstructured":"Wozniak O, Mierzejewski B, Brzoska E. MicroRNA-126: a key regulator of angiogenesis, inflammation, and tumorigenesis - Exploring its multifaceted functions in vascular health and cancer. Biochim Biophys Acta Mol Basis Dis. 2025;1871 (8):167984.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"4896_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2174\/1386207322666190325122821","volume":"25","author":"U Zaheer","year":"2019","unstructured":"Zaheer U, Faheem M, Qadri I, Begum N, Yassine HM, Al Thani AA, et al. Expression profile of microRNA: an emerging hallmark of cancer. Curr Pharm Des. 2019;25 (6):642\u201353.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"4896_CR11","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1007\/s00210-024-03153-0","volume":"397","author":"RU Syed","year":"2024","unstructured":"Syed RU, Alshammari MD, Banu H, Khojali WMA, Jafar M, Nagaraju P, et al. Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies. Naunyn Schmiedebergs Arch Pharmacol. 2024;397 (10):7421\u201337.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"4896_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41420-024-01823-9","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen J, Zou Z, Xu L, Li J. Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia. Cell Death Discov. 2024;10 (1):46.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4896_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s12672-024-01525-9","volume":"15","author":"J Wei","year":"2024","unstructured":"Wei J, Wang X, Yu D, Tu Y, Yu Y. MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies. Discov Oncol. 2024;15 (1):662.","journal-title":"Discov Oncol"},{"key":"4896_CR14","doi-asserted-by":"publisher","first-page":"177210","DOI":"10.1016\/j.ejphar.2024.177210","volume":"988","author":"S Dastghaib","year":"2025","unstructured":"Dastghaib S, Shafiee SM, Ramezani F, Ashtari N, Tabasi F, Saffari-Chaleshtori J, et al. NRF-mediated autophagy and UPR: exploring new avenues to overcome cancer chemo-resistance. Eur J Pharmacol. 2025;988:177210.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"4896_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mc.23886","volume":"64","author":"C Liang","year":"2025","unstructured":"Liang C, Long Z, Lei M, Ding R, Chen M. Integrated genomics reveal potential resistance mechanisms of panoptosis-associated genes in acute myeloid leukemia. Mol Carcinog. 2025;64 (5):801\u201315.","journal-title":"Mol Carcinog"},{"issue":"8","key":"4896_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24 (8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"4896_CR17","doi-asserted-by":"publisher","first-page":"EMBJ2021110031","DOI":"10.15252\/embj.2021110031","volume":"41","author":"RC Russell","year":"2022","unstructured":"Russell RC, Guan KL. The multifaceted role of autophagy in cancer. EMBO J. 2022;41 (13):EMBJ2021110031.","journal-title":"EMBO J"},{"key":"4896_CR18","doi-asserted-by":"publisher","first-page":"216307","DOI":"10.1016\/j.canlet.2023.216307","volume":"570","author":"Y Qin","year":"2023","unstructured":"Qin Y, Ashrafizadeh M, Mongiardini V, Grimaldi B, Crea F, Rietdorf K, et al. Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence. Cancer Lett. 2023;570:216307.","journal-title":"Cancer Lett"},{"key":"4896_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2023.04.004","volume":"203","author":"MJ Mallen-Ponce","year":"2023","unstructured":"Mallen-Ponce MJ, Gamez-Arcas S, Perez-Perez ME. Redox partner interactions in the ATG8 lipidation system in microalgae. Free Radic Biol Med. 2023;203:58\u201368.","journal-title":"Free Radic Biol Med"},{"key":"4896_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-015-0122-x","volume":"13","author":"MS Yoon","year":"2015","unstructured":"Yoon MS. Vps34 and PLD1 take center stage in nutrient signaling: their dual roles in regulating autophagy. Cell Commun Signal. 2015;13:44.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4896_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19 (1):12.","journal-title":"Mol Cancer"},{"issue":"1","key":"4896_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41420-023-01681-x","volume":"9","author":"S Xiao","year":"2023","unstructured":"Xiao S, Peng K, Li C, Long Y, Yu Q. The role of sphingosine-1-phosphate in autophagy and related disorders. Cell Death Discov. 2023;9 (1):380.","journal-title":"Cell Death Discov"},{"issue":"6","key":"4896_CR23","doi-asserted-by":"publisher","first-page":"e3000288","DOI":"10.1371\/journal.pbio.3000288","volume":"18","author":"Z Li","year":"2020","unstructured":"Li Z, Tian X, Ji X, Wang J, Chen H, Wang D, et al. ULK1-ATG13 and their mitotic phospho-regulation by CDK1 connect autophagy to cell cycle. PLoS Biol. 2020;18 (6):e3000288.","journal-title":"PLoS Biol"},{"issue":"12","key":"4896_CR24","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1080\/15548627.2023.2239633","volume":"19","author":"CY Lin","year":"2023","unstructured":"Lin CY, Wu KY, Chi LM, Tang YH, Huang HJ, Lai CH, et al. Starvation-inactivated MTOR triggers cell migration via a ULK1-SH3PXD2A\/TKS5-MMP14 pathway in ovarian carcinoma. Autophagy. 2023;19 (12):3151\u201368.","journal-title":"Autophagy"},{"issue":"2","key":"4896_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12265-024-10581-z","volume":"18","author":"Y Shen","year":"2025","unstructured":"Shen Y, Gleghorn JP, Class III. Phosphatidylinositol-3 kinase\/vacuolar protein sorting 34 in cardiovascular health and disease. J Cardiovasc Transl Res. 2025;18 (2):392\u2013407.","journal-title":"J Cardiovasc Transl Res"},{"key":"4896_CR26","doi-asserted-by":"publisher","first-page":"154100","DOI":"10.1016\/j.jplph.2023.154100","volume":"289","author":"T Wang","year":"2023","unstructured":"Wang T, Li X, Liu N, Yang Y, Gong Q. TurboID-based proximity labelling reveals a connection between VPS34 and cellular homeostasis. J Plant Physiol. 2023;289:154100.","journal-title":"J Plant Physiol"},{"issue":"1","key":"4896_CR27","doi-asserted-by":"publisher","first-page":"2277582","DOI":"10.1080\/27694127.2023.2277582","volume":"2","author":"NN Noda","year":"2023","unstructured":"Noda NN. Structural biology of the Atg8 and Atg12 conjugation systems. Autophagy Rep. 2023;2 (1):2277582.","journal-title":"Autophagy Rep"},{"key":"4896_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.mie.2016.09.055","volume":"587","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Qiu Y, Gunderson JE, Schulman BA. Production of Human ATG Proteins for Lipidation Assays. Methods Enzymol. 2017;587:97\u2013113.","journal-title":"Methods Enzymol"},{"issue":"1","key":"4896_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/15548627.2022.2083807","volume":"19","author":"Z Wu","year":"2023","unstructured":"Wu Z, Zhou C, Que H, Wang Y, Rong Y. The fate of autophagosomal membrane components. Autophagy. 2023;19 (1):370\u20131.","journal-title":"Autophagy"},{"issue":"1","key":"4896_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/15548627.2023.2247310","volume":"20","author":"M Borsa","year":"2024","unstructured":"Borsa M, Obba S, Richter FC, Zhang H, Riffelmacher T, Carrelha J, et al. Autophagy preserves hematopoietic stem cells by restraining MTORC1-mediated cellular anabolism. Autophagy. 2024;20 (1):45\u201357.","journal-title":"Autophagy"},{"issue":"20","key":"4896_CR31","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.3390\/cancers14205072","volume":"14","author":"O Garc\u00eda Ruiz","year":"2022","unstructured":"Garc\u00eda Ruiz O, S\u00e1nchez-Maldonado JM, L\u00f3pez-Nevot M\u00c1, Garc\u00eda P, Macauda A, Hern\u00e1ndez-Mohedo F, et al. Autophagy in hematological malignancies. Cancers. 2022;14 (20):5072.","journal-title":"Cancers"},{"key":"4896_CR32","doi-asserted-by":"crossref","unstructured":"Xiong Y, Chen T, Chen L, Cai R. Gold nanoparticles coated with SH-PEG-NH2 and loaded with ziyuglycoside I for promoting autophagy in hematopoietic stem cells. Int J Nanomed. 2023:1347\u201362.","DOI":"10.2147\/IJN.S399568"},{"issue":"4","key":"4896_CR33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.stem.2023.02.010","volume":"30","author":"BA Chua","year":"2023","unstructured":"Chua BA, Lennan CJ, Sunshine MJ, Dreifke D, Chawla A, Bennett EJ, et al. Hematopoietic stem cells preferentially traffic misfolded proteins to aggresomes and depend on aggrephagy to maintain protein homeostasis. Cell Stem Cell. 2023;30 (4):460\u201372. e6.","journal-title":"Cell Stem Cell"},{"issue":"23","key":"4896_CR34","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/cells12232742","volume":"12","author":"S Lee","year":"2023","unstructured":"Lee S, Son J-Y, Lee J, Cheong H. Unraveling the intricacies of autophagy and mitophagy: implications in cancer biology. Cells. 2023;12 (23):2742.","journal-title":"Cells"},{"issue":"15","key":"4896_CR35","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1111\/febs.16472","volume":"290","author":"KO Gudmundsson","year":"2023","unstructured":"Gudmundsson KO, Du Y. Quiescence regulation by normal haematopoietic stem cells and leukaemia stem cells. FEBS J. 2023;290 (15):3708\u201322.","journal-title":"FEBS J"},{"issue":"2","key":"4896_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/cancers14020381","volume":"14","author":"X Wang","year":"2022","unstructured":"Wang X, Lee J, Xie C. Autophagy regulation on cancer stem cell maintenance, metastasis, and therapy resistance. Cancers. 2022;14 (2):381.","journal-title":"Cancers"},{"issue":"12","key":"4896_CR37","doi-asserted-by":"publisher","first-page":"R684","DOI":"10.1016\/j.cub.2022.04.071","volume":"32","author":"C He","year":"2022","unstructured":"He C. Balancing nutrient and energy demand and supply via autophagy. Curr Biol. 2022;32 (12):R684\u201396.","journal-title":"Curr Biol"},{"issue":"4","key":"4896_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/iub.2569","volume":"74","author":"RL Yan","year":"2022","unstructured":"Yan RL, Chen RH. Autophagy and cancer metabolism-the two-way interplay. IUBMB Life. 2022;74 (4):281\u201395.","journal-title":"IUBMB Life"},{"key":"4896_CR39","doi-asserted-by":"publisher","first-page":"110275","DOI":"10.1016\/j.fsi.2025.110275","volume":"161","author":"L Deng","year":"2025","unstructured":"Deng L, Wang J, Liu Y, Wang L, Liu F, Lou B, et al. Hypoxia-induced mitochondrial dysfunction and mitophagy in the small yellow croaker (Larimichthys polyactis). Fish Shellfish Immunol. 2025;161:110275.","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"4896_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/dna.2018.4348","volume":"38","author":"P Fan","year":"2019","unstructured":"Fan P, Xie XH, Chen CH, Peng X, Zhang P, Yang C, et al. Molecular regulation mechanisms and interactions between reactive oxygen species and mitophagy. DNA Cell Biol. 2019;38 (1):10\u201322.","journal-title":"DNA Cell Biol"},{"issue":"5","key":"4896_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10495-023-01828-2","volume":"28","author":"X Liu","year":"2023","unstructured":"Liu X, Tang J, Peng L, Nie H, Zhang Y, Liu P. Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy: cancer-associated fibroblasts promote prostate cancer development. Apoptosis. 2023;28 (5):881\u201391.","journal-title":"Apoptosis"},{"issue":"3","key":"4896_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13237-021-00378-9","volume":"64","author":"SG Roy","year":"2021","unstructured":"Roy SG. Regulation of autophagy by miRNAs in human diseases. Nucleus. 2021;64 (3):317\u201329.","journal-title":"Nucleus"},{"key":"4896_CR43","doi-asserted-by":"crossref","unstructured":"Batara DCR, Choi MC, Shin HU, Kim H, Kim SH. Friend or foe: paradoxical roles of autophagy in gliomagenesis. Cells. 2021;10 (6).","DOI":"10.3390\/cells10061411"},{"key":"4896_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fcell.2018.00137","volume":"6","author":"MB Menon","year":"2018","unstructured":"Menon MB, Dhamija S. Beclin 1 Phosphorylation\u2014at the Center of Autophagy Regulation. Front Cell Dev Biol. 2018;6:137.","journal-title":"Front Cell Dev Biol"},{"key":"4896_CR45","doi-asserted-by":"crossref","unstructured":"Zachari M, Longo M, Ganley IG. Aberrant autophagosome formation occurs upon small molecule inhibition of ULK1 kinase activity. Life Sci Alliance. 2020;3 (12).","DOI":"10.26508\/lsa.202000815"},{"key":"4896_CR46","doi-asserted-by":"crossref","unstructured":"Xi H, Wang S, Wang B, Hong X, Liu X, Li M et al. The role of interaction between autophagy and apoptosis in tumorigenesis (Review). Oncol Rep. 2022;48 (6).","DOI":"10.3892\/or.2022.8423"},{"key":"4896_CR47","doi-asserted-by":"crossref","unstructured":"Rossin D, Perrelli MG, Lo Iacono M, Rastaldo R, Giachino C. Dynamic Interplay between autophagy and oxidative stress in stem cells: implications for regenerative medicine. Antioxid (Basel). 2025;14 (6).","DOI":"10.3390\/antiox14060691"},{"issue":"1","key":"4896_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s40001-025-03019-y","volume":"30","author":"NT Pourianazar","year":"2025","unstructured":"Pourianazar NT, Radmehr S, Ourang Z, Jaseb K, Asadi A. NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology. Eur J Med Res. 2025;30 (1):840.","journal-title":"Eur J Med Res"},{"issue":"3","key":"4896_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12291-023-01124-5","volume":"39","author":"RA Al-Qaisi","year":"2024","unstructured":"Al-Qaisi RA, Al-Gebori AM, Alosami MHM. Evaluation of bone turnover markers in patients with acute and chronic leukemia. Indian J Clin Biochem. 2024;39 (3):401\u20137.","journal-title":"Indian J Clin Biochem"},{"issue":"10","key":"4896_CR50","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1080\/15548627.2020.1822628","volume":"17","author":"W Du","year":"2021","unstructured":"Du W, Xu A, Huang Y, Cao J, Zhu H, Yang B, et al. The role of autophagy in targeted therapy for acute myeloid leukemia. Autophagy. 2021;17 (10):2665\u201379.","journal-title":"Autophagy"},{"issue":"1","key":"4896_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/27694127.2022.2139878","volume":"1","author":"S Yan","year":"2022","unstructured":"Yan S, Li J. ULK1 in autophagy: sugar it up. Autophagy Rep. 2022;1 (1):567\u20139.","journal-title":"Autophagy Rep"},{"issue":"1","key":"4896_CR52","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12935-024-03503-1","volume":"24","author":"Y Dong","year":"2024","unstructured":"Dong Y, He Y, Geng Y, Wei M, Zhou X, Lian J, et al. Autophagy-related lncRNAs and exosomal lncRNAs in colorectal cancer: focusing on lncRNA-targeted strategies. Cancer Cell Int. 2024;24 (1):328.","journal-title":"Cancer Cell Int"},{"issue":"26","key":"4896_CR53","doi-asserted-by":"publisher","first-page":"106113","DOI":"10.3748\/wjg.v31.i26.106113","volume":"31","author":"SH Zheng","year":"2025","unstructured":"Zheng SH, Xue TY, Wang QY, Ye YA, Zhang P. Chinese medicine monomers for hepatocellular carcinoma: New ideas related to autophagy. World J Gastroenterol. 2025;31 (26):106113.","journal-title":"World J Gastroenterol"},{"key":"4896_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.ircmb.2023.12.001","volume":"386","author":"R Shekhar","year":"2024","unstructured":"Shekhar R, Kumari S, Vergish S, Tripathi P. The crosstalk between miRNAs and signaling pathways in human cancers: potential therapeutic implications. Int Rev Cell Mol Biol. 2024;386:133\u201365.","journal-title":"Int Rev Cell Mol Biol"},{"key":"4896_CR55","doi-asserted-by":"publisher","first-page":"1257941","DOI":"10.3389\/fphar.2024.1257941","volume":"15","author":"Y Chang","year":"2024","unstructured":"Chang Y, Gao X, Jiang Y, Wang J, Liu L, Yan J, et al. Alpha-hederin reprograms multi-miRNAs activity and overcome small extracellular vesicles-mediated paclitaxel resistance in NSCLC. Front Pharmacol. 2024;15:1257941.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4896_CR56","first-page":"1621","volume":"15","author":"G Hu","year":"2018","unstructured":"Hu G, Zhao X, Wang J, Lv L, Wang C, Feng L, et al. miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1. Oncol Lett. 2018;15 (2):1621\u20139.","journal-title":"Oncol Lett"},{"key":"4896_CR57","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.biopha.2018.04.119","volume":"103","author":"WK Cheng","year":"2018","unstructured":"Cheng WK, Oon CE. How glycosylation aids tumor angiogenesis: an updated review. Biomed Pharmacother. 2018;103:1246\u201352.","journal-title":"Biomed Pharmacother"},{"key":"4896_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2019.02.044","volume":"452","author":"X Tang","year":"2019","unstructured":"Tang X, Tu G, Yang G, Wang X, Kang L, Yang L, et al. Autocrine TGF-beta1\/miR-200s\/miR-221\/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. Cancer Lett. 2019;452:79\u201389.","journal-title":"Cancer Lett"},{"issue":"1","key":"4896_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/CIRCRESAHA.115.307408","volume":"118","author":"A Chamorro-Jorganes","year":"2016","unstructured":"Chamorro-Jorganes A, Lee MY, Araldi E, Landskroner-Eiger S, Fernandez-Fuertes M, Sahraei M, et al. VEGF-induced expression of miR-17-92 cluster in endothelial cells is mediated by ERK\/ELK1 activation and regulates angiogenesis. Circ Res. 2016;118 (1):38\u201347.","journal-title":"Circ Res"},{"issue":"4","key":"4896_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12032-025-02641-4","volume":"42","author":"DD Shah","year":"2025","unstructured":"Shah DD, Chorawala MR, Raghani NR, Patel R, Fareed M, Kashid VA, et al. Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies. Med Oncol. 2025;42 (4):117.","journal-title":"Med Oncol"},{"key":"4896_CR61","doi-asserted-by":"publisher","first-page":"813747","DOI":"10.3389\/fimmu.2021.813747","volume":"12","author":"J Peng","year":"2021","unstructured":"Peng J, Liang Q, Xu Z, Cai Y, Peng B, Li J, et al. Current understanding of exosomal microRNAs in glioma immune regulation and therapeutic responses. Front Immunol. 2021;12:813747.","journal-title":"Front Immunol"},{"issue":"3","key":"4896_CR62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/1759-7714.14284","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Shi S, Wang Y, Zhang X, Liu X, Li J, et al. miR-223-3p targets FBXW7 to promote epithelial-mesenchymal transition and metastasis in breast cancer. Thorac Cancer. 2022;13 (3):474\u201382.","journal-title":"Thorac Cancer"},{"key":"4896_CR63","doi-asserted-by":"publisher","first-page":"106880","DOI":"10.1016\/j.phrs.2023.106880","volume":"195","author":"B Xia","year":"2023","unstructured":"Xia B, Liu Y, Wang J, Lu Q, Lv X, Deng K, et al. Emerging role of exosome-shuttled noncoding RNAs in gastrointestinal cancers: From intercellular crosstalk to clinical utility. Pharmacol Res. 2023;195:106880.","journal-title":"Pharmacol Res"},{"issue":"2","key":"4896_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/mco.2023.2712","volume":"20","author":"S Takamizawa","year":"2024","unstructured":"Takamizawa S, Kojima J, Umezu T, Kuroda M, Hayashi S, Maruta T, et al. miR\u2013146a\u20135p and miR\u2013191\u20135p as novel diagnostic marker candidates for ovarian clear cell carcinoma. Mol Clin Oncol. 2024;20 (2):14.","journal-title":"Mol Clin Oncol"},{"key":"4896_CR65","doi-asserted-by":"publisher","first-page":"118357","DOI":"10.1016\/j.ecoenv.2025.118357","volume":"299","author":"L Zhu","year":"2025","unstructured":"Zhu L, Ying S, Su X, Yu W, Yan K, Shen W, et al. A four-miRNA signature as a potential biomarker of malignant mesothelioma patients from hand-spinning asbestos exposed area in Eastern China. Ecotoxicol Environ Saf. 2025;299:118357.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"8","key":"4896_CR66","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1007\/s00210-024-03076-w","volume":"397","author":"DE Ellakwa","year":"2024","unstructured":"Ellakwa DE, Mushtaq N, Khan S, Jabbar A, Abdelmalek MA, Wadan AS, et al. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance. Naunyn Schmiedebergs Arch Pharmacol. 2024;397 (8):5617\u201330.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4896_CR67","doi-asserted-by":"crossref","unstructured":"Abadi AJ, Zarrabi A, Gholami MH, Mirzaei S, Hashemi F, Zabolian A et al. Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers. Biomolecules. 2021;11 (2).","DOI":"10.3390\/biom11020304"},{"issue":"4","key":"4896_CR68","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.3892\/or.2017.5484","volume":"37","author":"J Xiao","year":"2017","unstructured":"Xiao J, Yu W, Hu K, Li M, Chen J, Li Z. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN\/AKT signaling pathway. Oncol Rep. 2017;37 (4):2513\u201321.","journal-title":"Oncol Rep"},{"issue":"1","key":"4896_CR69","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12672-025-03073-2","volume":"16","author":"SFJ Hussain","year":"2025","unstructured":"Hussain SFJ, Fareed M, Karobari MI. miRNA regulation of the Akt\/mTOR pathway in oral squamous cell carcinoma: a focused review. Discov Oncol. 2025;16 (1):1355.","journal-title":"Discov Oncol"},{"key":"4896_CR70","doi-asserted-by":"crossref","unstructured":"Gorshkov A, Purvinsh L, Brodskaia A, Vasin A. Exosomes as natural nanocarriers for RNA-based therapy and prophylaxis. Nanomaterials (Basel). 2022;12(3).","DOI":"10.3390\/nano12030524"},{"issue":"14","key":"4896_CR71","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.18632\/aging.103520","volume":"12","author":"TJ Zhang","year":"2020","unstructured":"Zhang TJ, Zhang LC, Xu ZJ, Zhou JD. Expression and prognosis analysis of DNMT family in acute myeloid leukemia. Aging. 2020;12(14):14677\u201390.","journal-title":"Aging"},{"issue":"12","key":"4896_CR72","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/leu.2016.112","volume":"30","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Zhang H, Wang Y, Li X, Lu P, Dong F, et al. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression. Leukemia. 2016;30 (12):2373\u201384.","journal-title":"Leukemia"},{"issue":"1","key":"4896_CR73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7150\/thno.77404","volume":"13","author":"S Ye","year":"2023","unstructured":"Ye S, Xiong F, He X, Yuan Y, Li D, Ye D, et al. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax. Theranostics. 2023;13 (1):77\u201394.","journal-title":"Theranostics"},{"issue":"4","key":"4896_CR74","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.18632\/oncotarget.23150","volume":"9","author":"A Ngankeu","year":"2018","unstructured":"Ngankeu A, Ranganathan P, Havelange V, Nicolet D, Volinia S, Powell BL, et al. Discovery and functional implications of a miR-29b-1\/miR-29a cluster polymorphism in acute myeloid leukemia. Oncotarget. 2018;9 (4):4354\u201365.","journal-title":"Oncotarget"},{"issue":"1","key":"4896_CR75","doi-asserted-by":"publisher","first-page":"e2071","DOI":"10.1038\/cddis.2015.419","volume":"7","author":"A Bresin","year":"2016","unstructured":"Bresin A, D\u2019Abundo L, Narducci MG, Fiorenza MT, Croce CM, Negrini M, et al. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia. Cell Death Dis. 2016;7 (1):e2071.","journal-title":"Cell Death Dis"},{"key":"4896_CR76","doi-asserted-by":"crossref","unstructured":"Skelin J, Matulic M, Milkovic L, Heckel D, Skoko J, Skreb KA et al. Analysis of primary chronic lymphocytic leukemia cells\u2019 signaling pathways. Biomedicines. 2024;12 (3).","DOI":"10.3390\/biomedicines12030524"},{"issue":"1","key":"4896_CR77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ijlh.13116","volume":"42","author":"P Xu","year":"2020","unstructured":"Xu P, Zhou D, Yan G, Ouyang J, Chen B. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia. Int J Lab Hematol. 2020;42 (1):16\u201322.","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"4896_CR78","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/leu.2015.106","volume":"29","author":"J Khalife","year":"2015","unstructured":"Khalife J, Radomska HS, Santhanam R, Huang X, Neviani P, Saultz J, et al. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. Leukemia. 2015;29 (10):1981\u201392.","journal-title":"Leukemia"},{"issue":"1","key":"4896_CR79","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12967-022-03500-w","volume":"20","author":"L Liu","year":"2022","unstructured":"Liu L, Yang L, Liu X, Liu M, Liu J, Feng X, et al. SEMA4D\/PlexinB1 promotes AML progression via activation of PI3K\/Akt signaling. J Transl Med. 2022;20 (1):304.","journal-title":"J Transl Med"},{"key":"4896_CR80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fmed.2020.00196","volume":"7","author":"MP Roffel","year":"2020","unstructured":"Roffel MP, Bracke KR, Heijink IH, Maes T. miR-223: a key regulator in the innate immune response in asthma and COPD. Front Med (Lausanne). 2020;7:196.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"4896_CR81","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3233\/CBM-181381","volume":"22","author":"Y Huang","year":"2018","unstructured":"Huang Y, Zou Y, Lin L, Ma X, Chen H. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia. Cancer Biomark. 2018;22 (4):799\u2013805.","journal-title":"Cancer Biomark"},{"issue":"10","key":"4896_CR82","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1002\/jcp.29610","volume":"235","author":"J Matuszyk","year":"2020","unstructured":"Matuszyk J, Klopotowska D. miR-125b lowers sensitivity to apoptosis following mitotic arrest: Implications for breast cancer therapy. J Cell Physiol. 2020;235 (10):6335\u201344.","journal-title":"J Cell Physiol"},{"issue":"19","key":"4896_CR83","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1182\/bloodadvances.2020003490","volume":"6","author":"T Katsumoto","year":"2022","unstructured":"Katsumoto T, Ogawara Y, Yamagata K, Aikawa Y, Goitsuka R, Nakamura T, et al. MOZ is critical for the development of MOZ\/MLL fusion-induced leukemia through regulation of Hoxa9\/Meis1 expression. Blood Adv. 2022;6 (19):5527\u201337.","journal-title":"Blood Adv"},{"issue":"11","key":"4896_CR84","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/rda.13551","volume":"54","author":"S Zhang","year":"2019","unstructured":"Zhang S, Wang L, Wang L, Chen Y, Li F. miR-17-5p affects porcine granulosa cell growth and oestradiol synthesis by targeting E2F1 gene. Reprod Domest Anim. 2019;54 (11):1459\u201369.","journal-title":"Reprod Domest Anim"},{"key":"4896_CR85","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.2147\/OTT.S126819","volume":"10","author":"Y Huang","year":"2017","unstructured":"Huang Y, Hong X, Hu J, Lu Q. Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562\/A02. Onco Targets Ther. 2017;10:3233\u20139.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"4896_CR86","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/s41419-021-04353-9","volume":"12","author":"I Kapoor","year":"2021","unstructured":"Kapoor I, Bodo J, Hill BT, Almasan A. Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies. Cell Death Dis. 2021;12 (11):1061.","journal-title":"Cell Death Dis"},{"issue":"18","key":"4896_CR87","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1182\/blood.2020005627","volume":"137","author":"S Sharma","year":"2021","unstructured":"Sharma S, Pavlasova GM, Seda V, Cerna KA, Vojackova E, Filip D, et al. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. Blood. 2021;137 (18):2481\u201394.","journal-title":"Blood"},{"issue":"6","key":"4896_CR88","first-page":"9051","volume":"15","author":"Y Hua","year":"2018","unstructured":"Hua Y, Liang C, Miao C, Wang S, Su S, Shao P, et al. MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Oncol Lett. 2018;15 (6):9051\u201360.","journal-title":"Oncol Lett"},{"issue":"1","key":"4896_CR89","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1570159X22666240704123701","volume":"23","author":"L Ouyang","year":"2024","unstructured":"Ouyang L, Xia W, Al-Alwany AA, Gupta R, Sapaev I, Almalki SG, et al. Ischemic stroke and autophagy: the roles of long non-coding RNAs. Curr Neuropharmacol. 2024;23 (1):85\u201397.","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"4896_CR90","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-024-06677-8","volume":"15","author":"Y Ding","year":"2024","unstructured":"Ding Y, Huang X, Ji T, Qi C, Gao X, Wei R. The emerging roles of miRNA-mediated autophagy in ovarian cancer. Cell Death Dis. 2024;15 (5):314.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4896_CR91","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4149\/neo_2020_200106N17","volume":"68","author":"Q Yu","year":"2021","unstructured":"Yu Q, Xu XP, Yin XM, Peng XQ. miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy. Neoplasma. 2021;68 (1):87\u201395.","journal-title":"Neoplasma"},{"issue":"6","key":"4896_CR92","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.cellin.2023.100127","volume":"2","author":"L Sun","year":"2023","unstructured":"Sun L, Wang X, Chen L, Gao Z, Xu S, Hu C, et al. CPT1A mediates chemoresistance in human hypopharyngeal squamous cell carcinoma via ATG16L1-dependent cellular autophagy. Cell Insight. 2023;2 (6):100127.","journal-title":"Cell Insight"},{"issue":"5","key":"4896_CR93","first-page":"6859","volume":"17","author":"J Chen","year":"2018","unstructured":"Chen J, Zhang L, Zhou H, Wang W, Luo Y, Yang H, et al. Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells. Mol Med Rep. 2018;17 (5):6859\u201365.","journal-title":"Mol Med Rep"},{"issue":"4","key":"4896_CR94","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3892\/ijmm.2016.2492","volume":"37","author":"S Tan","year":"2016","unstructured":"Tan S, Shi H, Ba M, Lin S, Tang H, Zeng X, et al. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Mol Med. 2016;37 (4):1030\u20138.","journal-title":"Int J Mol Med"},{"issue":"6","key":"4896_CR95","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3892\/etm.2021.10900","volume":"22","author":"W Wang","year":"2021","unstructured":"Wang W, Chen L, Zhu W, Huang X, Lin L, Quan Z, et al. miR-4486 reverses cisplatin-resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy. Exp Ther Med. 2021;22 (6):1465.","journal-title":"Exp Ther Med"},{"issue":"3","key":"4896_CR96","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1159\/000481754","volume":"43","author":"X Yang","year":"2017","unstructured":"Yang X, Bai F, Xu Y, Chen Y, Chen L. Intensified beclin-1 mediated by low expression of mir-30a-5p promotes chemoresistance in human small cell lung cancer. Cell Physiol Biochem. 2017;43 (3):1126\u201339.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"4896_CR97","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12079-022-00702-1","volume":"17","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Taheriazam A, Daneii P, Hassanpour A, Kakavand A, Rezaei S, et al. Targeting PI3K\/Akt signaling in prostate cancer therapy. J Cell Commun Signal. 2023;17 (3):423\u201343.","journal-title":"J Cell Commun Signal"},{"issue":"4","key":"4896_CR98","first-page":"1631","volume":"39","author":"J Liu","year":"2018","unstructured":"Liu J, Xing Y, Rong L. miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN\/PI3K\/AKT pathway. Oncol Rep. 2018;39 (4):1631\u20139.","journal-title":"Oncol Rep"},{"issue":"1","key":"4896_CR99","first-page":"248","volume":"69","author":"L Kma","year":"2022","unstructured":"Kma L, Baruah TJ. The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation. Biotechnol Appl Chem. 2022;69 (1):248\u201364.","journal-title":"Biotechnol Appl Chem"},{"issue":"1","key":"4896_CR100","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s44313-025-00107-0","volume":"60","author":"AM Chahardehi","year":"2025","unstructured":"Chahardehi AM, Mali E, Afrooghe A, Asadi A, Khalaji A, Samarkhazan HS, et al. Unveiling the role of microRNAs, the PI3K\/AKT pathway, and their associations in various types of leukemia: a comprehensive review. Blood Res. 2025;60 (1):56.","journal-title":"Blood Res"},{"issue":"8","key":"4896_CR101","first-page":"e70264","volume":"8","author":"M Kargar","year":"2025","unstructured":"Kargar M, Allahbakhshian Farsani M, Garavand J, Gorji M, Rafiee M, Bahreiny SS, et al. Targeting the mTOR signaling pathway through miR-100 and miR-101 in De Novo acute myeloid leukemia: implications for therapeutic intervention. Cancer Rep (Hoboken). 2025;8 (8):e70264.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"11","key":"4896_CR102","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/gt.2017.88","volume":"24","author":"M Tager","year":"2017","unstructured":"Tager M, Horn S, Latuske E, Ehm P, Schaks M, Nalaskowski M, et al. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model. Gene Ther. 2017;24 (11):749\u201353.","journal-title":"Gene Ther"},{"issue":"5","key":"4896_CR103","doi-asserted-by":"publisher","first-page":"e0277423","DOI":"10.1128\/spectrum.02774-23","volume":"11","author":"M Suzuki","year":"2023","unstructured":"Suzuki M, Funakoshi T, Kumagai K, Komatsu M, Waguri S. ATG9A supports Chlamydia trachomatis infection via autophagy-independent mechanisms. Microbiol Spectr. 2023;11 (5):e0277423.","journal-title":"Microbiol Spectr"},{"key":"4896_CR104","doi-asserted-by":"publisher","first-page":"112895","DOI":"10.1016\/j.ecoenv.2021.112895","volume":"227","author":"H Zou","year":"2021","unstructured":"Zou H, Wang L, Zhao J, Yuan Y, Wang T, Bian J, et al. MiR-155 promotes cadmium-induced autophagy in rat hepatocytes by suppressing Rheb expression. Ecotoxicol Environ Saf. 2021;227:112895.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"6","key":"4896_CR105","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1080\/15548627.2024.2312035","volume":"20","author":"SY Wu","year":"2024","unstructured":"Wu SY, Chu CA, Lan SH, Liu HS. Degradative autophagy regulates the homeostasis of miRnas to control cancer development. Autophagy. 2024;20 (6):1444\u20136.","journal-title":"Autophagy"},{"key":"4896_CR106","doi-asserted-by":"publisher","first-page":"108640","DOI":"10.1016\/j.pharmthera.2024.108640","volume":"258","author":"AV Lee","year":"2024","unstructured":"Lee AV, Nestler KA, Chiappinelli KB. Therapeutic targeting of DNA methylation alterations in cancer. Pharmacol Ther. 2024;258:108640.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"4896_CR107","first-page":"387","volume":"45","author":"X Li","year":"2016","unstructured":"Li X, Zhu L, Ye X. [Aberrant DNA methylation and its targeted therapy in acute myeloid leukemia]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016;45 (4):387\u201394.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"4896_CR108","first-page":"1169","volume":"43","author":"CY Meng","year":"2020","unstructured":"Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX, Xue HQ, et al. MicroRNA\u201322 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K\/Akt\/mTOR pathway. Oncol Rep. 2020;43 (4):1169\u201386.","journal-title":"Oncol Rep"},{"issue":"3","key":"4896_CR109","first-page":"790","volume":"27","author":"C Wen","year":"2019","unstructured":"Wen C, Xie YK, Chen YJ. [Efflect of miR-34a-Tangeted Regulation of HDACI on Apoptosis of AML Cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27 (3):790\u20135.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"2","key":"4896_CR110","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1159\/000490027","volume":"47","author":"L Huang","year":"2018","unstructured":"Huang L, Hu C, Cao H, Wu X, Wang R, Lu H, et al. MicroRNA-29c increases the chemosensitivity of pancreatic cancer cells by inhibiting USP22 mediated autophagy. Cell Physiol Biochem. 2018;47 (2):747\u201358.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"4896_CR111","doi-asserted-by":"publisher","first-page":"2257538","DOI":"10.1080\/15592294.2023.2257538","volume":"18","author":"X Liu","year":"2023","unstructured":"Liu X, Liu Z, Liu Y, Wang N. ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells. Epigenetics. 2023;18 (1):2257538.","journal-title":"Epigenetics"},{"issue":"2","key":"4896_CR112","first-page":"447","volume":"8","author":"Q Li","year":"2016","unstructured":"Li Q, Wu Y, Zhang Y, Sun H, Lu Z, Du K, et al. miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1. Am J Transl Res. 2016;8 (2):447\u201359.","journal-title":"Am J Transl Res"},{"issue":"2","key":"4896_CR113","first-page":"336","volume":"26","author":"J Liu","year":"2018","unstructured":"Liu J, Tong CQ. [Inhibitory effect of miR-125b Down-regulation on proliferation of leukemia cell K562]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26 (2):336\u201340.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"19","key":"4896_CR114","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2174\/1389557523666230328125031","volume":"23","author":"M Wang","year":"2023","unstructured":"Wang M, Huo Z, He X, Liu F, Liang J, Wu L, et al. The role of MiR-29 in the mechanism of fibrosis. Mini Rev Med Chem. 2023;23 (19):1846\u201358.","journal-title":"Mini Rev Med Chem"},{"key":"4896_CR115","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuroscience.2022.03.033","volume":"491","author":"H Xiong","year":"2022","unstructured":"Xiong H, Pang J, Min X, Ye Y, Lai L, Zheng Y. miR-34a\/ATG9A\/TFEB signaling modulates autophagy in cochlear hair cells and correlates with age-related hearing loss. Neuroscience. 2022;491:98\u2013109.","journal-title":"Neuroscience"},{"issue":"1","key":"4896_CR116","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43556-022-00110-2","volume":"3","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Luo T, Shi H. Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy. Mol Biomed. 2022;3 (1):47.","journal-title":"Mol Biomed"},{"issue":"1","key":"4896_CR117","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jds.2023.08.013","volume":"19","author":"Y-F Su","year":"2024","unstructured":"Su Y-F, Lin C-S, Shen P-C, Chuang S-E, Dai Y-H, Huang T-W, et al. MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl\/Akt\/GSK-3\u03b2 pathway. J Dent Sci. 2024;19 (1):428\u201337.","journal-title":"J Dent Sci"},{"issue":"8","key":"4896_CR118","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41418-023-01193-2","volume":"30","author":"Z Huang","year":"2023","unstructured":"Huang Z, Kaller M, Hermeking H. CRISPR\/Cas9-mediated inactivation of miR-34a and miR-34b\/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34. Cell Death Differ. 2023;30 (8):2017\u201334.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4896_CR119","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s13071-025-07033-1","volume":"18","author":"S Wu","year":"2025","unstructured":"Wu S, Shao T, Li J, Xie J, Sun L, Zhang Y, et al. MiR-125b-5p targets Bak1 to regulate HCT-8 cell apoptosis in response to Cryptosporidium parvum infection via mitochondrial pathway. Parasites Vectors. 2025;18 (1):435.","journal-title":"Parasites Vectors"},{"issue":"1","key":"4896_CR120","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40164-025-00644-5","volume":"14","author":"P Gao","year":"2025","unstructured":"Gao P, Zhang Y, Ma J, Zhang Y. Immunotherapy in chronic lymphocytic leukemia: advances and challenges. Exp Hematol Oncol. 2025;14 (1):53.","journal-title":"Exp Hematol Oncol"},{"key":"4896_CR121","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.omto.2020.01.004","volume":"16","author":"F Raeisi","year":"2020","unstructured":"Raeisi F, Mahmoudi E, Dehghani-Samani M, Hosseini SSE, Ghahfarrokhi AM, Arshi A, et al. Differential expression profile of miR-27b, miR-29a, and miR-155 in chronic lymphocytic leukemia and breast cancer patients. Mol Ther Oncolytics. 2020;16:230\u20137.","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"4896_CR122","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1186\/s12885-018-4915-3","volume":"18","author":"YQ Yang","year":"2018","unstructured":"Yang YQ, Tian T, Zhu HY, Liang JH, Wu W, Wu JZ, et al. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia. BMC Cancer. 2018;18 (1):1009.","journal-title":"BMC Cancer"},{"issue":"8","key":"4896_CR123","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3324\/haematol.2021.279924","volume":"107","author":"VK Schmid","year":"2022","unstructured":"Schmid VK, Khadour A, Ahmed N, Brandl C, Nitschke L, Rajewsky K, et al. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia. Haematologica. 2022;107 (8):1796\u2013814.","journal-title":"Haematologica"},{"issue":"6","key":"4896_CR124","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4014\/jmb.1811.11062","volume":"29","author":"S Ding","year":"2019","unstructured":"Ding S, Qu Y, Yang S, Zhao Y, Xu G. Novel miR-1958 promotes mycobacterium tuberculosis survival in RAW264.7 cells by inhibiting autophagy via Atg5. J Microbiol Biotechnol. 2019;29 (6):989\u201398.","journal-title":"J Microbiol Biotechnol"},{"issue":"4","key":"4896_CR125","first-page":"1104","volume":"11","author":"M Lv","year":"2021","unstructured":"Lv M, Zhu S, Peng H, Cheng Z, Zhang G, Wang Z. B-cell acute lymphoblastic leukemia-related microRNAs: uncovering their diverse and special roles. Am J Cancer Res. 2021;11 (4):1104\u201320.","journal-title":"Am J Cancer Res"},{"key":"4896_CR126","doi-asserted-by":"publisher","first-page":"1390571","DOI":"10.1155\/2016\/1390571","volume":"2016","author":"D Kubota","year":"2016","unstructured":"Kubota D, Kosaka N, Fujiwara T, Yoshida A, Arai Y, Qiao Z, et al. miR-125b and miR-100 are predictive biomarkers of response to induction chemotherapy in osteosarcoma. Sarcoma. 2016;2016:1390571.","journal-title":"Sarcoma"},{"issue":"6","key":"4896_CR127","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14715\/cmb\/2018.64.6.5","volume":"64","author":"Y Hekmatshoar","year":"2018","unstructured":"Hekmatshoar Y, Ozkan T, Altinok Gunes B, Bozkurt S, Karadag A, Karabay AZ, et al. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms. Cell Mol Biol (Noisy-le-grand). 2018;64 (6):23\u201330.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"4896_CR128","doi-asserted-by":"crossref","unstructured":"Senapati J, Sasaki K. Chromosomal instability in chronic myeloid leukemia: mechanistic insights and effects. Cancers (Basel). 2022;14(10).","DOI":"10.3390\/cancers14102533"},{"issue":"1","key":"4896_CR129","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12672-025-02413-6","volume":"16","author":"X Lei","year":"2025","unstructured":"Lei X, Zheng Y, Su W. RNA-binding proteins and autophagy in lung cancer: mechanistic insights and therapeutic perspectives. Discov Oncol. 2025;16 (1):599.","journal-title":"Discov Oncol"},{"issue":"5","key":"4896_CR130","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00277-023-05383-3","volume":"103","author":"A Rahmati","year":"2024","unstructured":"Rahmati A, Mafi A, Vakili O, Soleymani F, Alishahi Z, Yahyazadeh S, et al. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways. Ann Hematol. 2024;103 (5):1455\u201382.","journal-title":"Ann Hematol"},{"key":"4896_CR131","doi-asserted-by":"crossref","unstructured":"Chen N, Zhang Y, Jiang Y, Gao G, Li J, Shi W. The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic Leukemia. Curr Pharm Design. 2025.","DOI":"10.2174\/0113816128361848250401200001"},{"issue":"1","key":"4896_CR132","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/ijms25010119","volume":"25","author":"D Barrios-Palacios","year":"2023","unstructured":"Barrios-Palacios D, Organista-Nava J, Balandr\u00e1n JC, Alarc\u00f3n-Romero LdC, Zubillaga-Guerrero MI, Illades-Aguiar B, et al. The role of miRNAs in childhood acute lymphoblastic leukemia relapse and the associated molecular mechanisms. Int J Mol Sci. 2023;25 (1):119.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4896_CR133","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12964-023-01259-1","volume":"21","author":"K Otmani","year":"2023","unstructured":"Otmani K, Rouas R, Lagneaux L, Krayem M, Duvillier H, Berehab M, et al. Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN\/MADD targeting in the NF-\u03baB signaling pathways. Cell Communication Signal. 2023;21 (1):253.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"4896_CR134","doi-asserted-by":"publisher","first-page":"79","DOI":"10.61186\/JBUMS.31.1.79","volume":"31","author":"M Edalati","year":"2024","unstructured":"Edalati M, Sh A, Abdoli A, Karam F, Shekarchi A, Sayadi M. Upregulation of miR-155 induces cell cycle arrest and apoptosis in chronic myeloid leukemia. J Birjand Univ Med Sci. 2024;31 (1):79\u201390.","journal-title":"J Birjand Univ Med Sci"},{"issue":"7","key":"4896_CR135","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-11-3671","volume":"72","author":"V Kovaleva","year":"2012","unstructured":"Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012;72 (7):1763\u201372.","journal-title":"Cancer Res"},{"issue":"1","key":"4896_CR136","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s12672-025-03686-7","volume":"16","author":"A Faghiri Beyrami","year":"2025","unstructured":"Faghiri Beyrami A, Movasaghpour Akbari AA, Aghebati-Maleki L, Dolati S, Yousefi M. The crosstalk between MiRNAs and autophagy in leukemia: mechanisms and therapeutic insights. Discov Oncol. 2025;16 (1):1917.","journal-title":"Discov Oncol"},{"issue":"2","key":"4896_CR137","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/bpa.12267","volume":"26","author":"H Wang","year":"2016","unstructured":"Wang H, Ye Y, Zhu Z, Mo L, Lin C, Wang Q, et al. MiR-124 regulates apoptosis and autophagy process in MPTP Model of Parkinson\u2019s disease by targeting to Bim. Brain Pathol. 2016;26 (2):167\u201376.","journal-title":"Brain Pathol"},{"issue":"1","key":"4896_CR138","first-page":"580","volume":"2016","author":"EA Raetz","year":"2016","unstructured":"Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematol 2014 Am Soc Hematol Educ Program Book. 2016;2016 (1):580\u20138.","journal-title":"Hematol 2014 Am Soc Hematol Educ Program Book"},{"key":"4896_CR139","unstructured":"Hamdy NM, Abulsoud AI, Rizk NI, Nashoaty T, Zaki MB, Sultan AS et al. The Epigenetic Angle in the Precision. From (Epi) genetics-to-Precision (E2P): Non-protein Coding RNAs (ncRNAs) a Step-toward Precision Medicine.299."},{"key":"4896_CR140","doi-asserted-by":"publisher","first-page":"143249","DOI":"10.1016\/j.ijbiomac.2025.143249","volume":"310","author":"H Zhang","year":"2025","unstructured":"Zhang H, Song T, Song Y, Hu Z, Soliman ME, Jiang M, et al. A kinase-independent Bcr-Abl function mediating an Hsp70-Bim protein-protein interaction in chronic myeloid leukemia. Int J Biol Macromol. 2025;310:143249.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"4896_CR141","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang Y-K, Borad M, Sachdev J, Ejadi S, Lim HY, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122 (11):1630\u20137.","journal-title":"Br J Cancer"},{"issue":"3","key":"4896_CR142","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.18632\/oncotarget.23231","volume":"9","author":"Y-X Tu","year":"2017","unstructured":"Tu Y-X, Wang S-B, Fu L-Q, Li S-S, Guo Q-P, Wu Y, et al. Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K\/AKT\/mTOR pathway. Oncotarget. 2017;9 (3):3267.","journal-title":"Oncotarget"},{"issue":"1","key":"4896_CR143","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s11658-024-00571-z","volume":"29","author":"T Wang","year":"2024","unstructured":"Wang T, He M, Zhang X, Guo Z, Wang P, Long F. Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective. Cell Mol Biol Lett. 2024;29 (1):60.","journal-title":"Cell Mol Biol Lett"},{"issue":"40","key":"4896_CR144","doi-asserted-by":"publisher","first-page":"67709","DOI":"10.18632\/oncotarget.18810","volume":"8","author":"G Stefanzl","year":"2017","unstructured":"Stefanzl G, Berger D, Cerny-Reiterer S, Blatt K, Eisenwort G, Sperr WR, et al. The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase\/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells. Oncotarget. 2017;8 (40):67709\u201322.","journal-title":"Oncotarget"},{"issue":"1","key":"4896_CR145","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41420-025-02632-4","volume":"11","author":"T Huang","year":"2025","unstructured":"Huang T, Takagi S, Koike S, Katayama R. Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastoma. Cell Death Discov. 2025;11 (1):340.","journal-title":"Cell Death Discov"},{"issue":"3","key":"4896_CR146","first-page":"184","volume":"5","author":"F Majidi","year":"2024","unstructured":"Majidi F, Gattermann N, Imetelstat. Finally a disease-modifying treatment for lower-risk myelodysplastic. syndromes? Med. 2024;5 (3):184\u20136.","journal-title":"syndromes? Med"},{"key":"4896_CR147","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.1016\/j.blre.2023.101057","volume":"60","author":"A Ohmoto","year":"2023","unstructured":"Ohmoto A, Fuji S. Prospects of early therapeutic interventions for indolent adult T-cell leukemia\/lymphoma based on the chronic lymphocytic leukemia progression model. Blood Rev. 2023;60:101057.","journal-title":"Blood Rev"},{"issue":"9","key":"4896_CR148","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1097\/HS9.0000000000000938","volume":"7","author":"MV Haselager","year":"2023","unstructured":"Haselager MV, van Driel BF, Perelaer E, de Rooij D, Lashgari D, Loos R, et al. In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival. Hemasphere. 2023;7 (9):e938.","journal-title":"Hemasphere"},{"key":"4896_CR149","doi-asserted-by":"crossref","unstructured":"Manivannan MS, Yang X, Patel N, Peters A, Johnston JB, Gibson SB. Lysosome-disrupting agents in combination with venetoclax increase apoptotic response in primary chronic lymphocytic leukemia (CLL) cells mediated by lysosomal cathepsin D release and inhibition of autophagy. Cells. 2024;13 (12).","DOI":"10.3390\/cells13121041"},{"issue":"3","key":"4896_CR150","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s13577-020-00367-1","volume":"33","author":"YL Li","year":"2020","unstructured":"Li YL, Tang JM, Chen XY, Luo B, Liang GH, Qu Q, et al. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy. Hum Cell. 2020;33 (3):610\u20138.","journal-title":"Hum Cell"},{"issue":"20","key":"4896_CR151","doi-asserted-by":"publisher","first-page":"20111","DOI":"10.18632\/aging.103614","volume":"12","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kang J, Liu L, Chen L, Ren S, Tao Y. MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy. Aging. 2020;12 (20):20111\u201326.","journal-title":"Aging"},{"key":"4896_CR152","doi-asserted-by":"crossref","unstructured":"Silva VR, Neves SP, Santos LS, Dias RB, Bezerra DP. Challenges and therapeutic opportunities of autophagy in cancer therapy. Cancers (Basel). 2020;12(11).","DOI":"10.3390\/cancers12113461"},{"issue":"1","key":"4896_CR153","doi-asserted-by":"publisher","first-page":"5517777","DOI":"10.1155\/2021\/5517777","volume":"2021","author":"H-Y Lin","year":"2021","unstructured":"Lin H-Y, Chu P-Y. Advances in understanding mitochondrial microRNAs (mitomirs) on the pathogenesis of triple-negative breast cancer (TNBC). Oxidative Med Cell Longev. 2021;2021 (1):5517777.","journal-title":"Oxidative Med Cell Longev"},{"key":"4896_CR154","doi-asserted-by":"crossref","unstructured":"Naik KAP, Nayak KS, Rosangzula K, Saikrishna J, Sangeetha R, Patlolla RR, et al. Restoring tumor suppression activity: mimicking molecules (TargomiRs and MRX34) and synthetic RNAs (MTL-CEBPA). Enzyme Based Approaches in Cancer Healthcare Management. Springer; 2026. pp. 295\u2013378.","DOI":"10.1007\/978-981-95-5071-5_12"},{"issue":"Suppl 1","key":"4896_CR155","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.21037\/tlcr.2018.01.11","volume":"7","author":"N van Zandwijk","year":"2018","unstructured":"van Zandwijk N, McDiarmid J, Brahmbhatt H, Reid G. Response to An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs). Translational Lung Cancer Res. 2018;7 (Suppl 1):S60.","journal-title":"Translational Lung Cancer Res"},{"key":"4896_CR156","doi-asserted-by":"crossref","unstructured":"Chen G, Wang S, Wang F, Yang C, Zhang R, Liu P et al. Targeted inhibition of MDSC-derived exosomal miR-155-5p restrains epithelial-mesenchymal transition in hormone receptor-positive breast cancer by regulating SIRT1. Mater Today Bio. 2025:102492.","DOI":"10.1016\/j.mtbio.2025.102492"},{"issue":"2","key":"4896_CR157","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00280-016-3197-1","volume":"79","author":"T-T Shi","year":"2017","unstructured":"Shi T-T, Yu X-X, Yan L-J, Xiao H-T. Research progress of hydroxychloroquine and autophagy inhibitors on cancer. Cancer Chemother Pharmacol. 2017;79 (2):287\u201394.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"4896_CR158","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/1078-0432.CCR-21-3382","volume":"28","author":"JM Mehnert","year":"2022","unstructured":"Mehnert JM, Mitchell TC, Huang AC, Aleman TS, Kim BJ, Schuchter LM, et al. BAMM (BRAF autophagy and MEK inhibition in melanoma): a phase I\/II trial of dabrafenib, trametinib, and hydroxychloroquine in advanced BRAFV600-mutant melanoma. Clin Cancer Res. 2022;28 (6):1098\u2013106.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4896_CR159","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41416-020-01039-5","volume":"124","author":"M Piffoux","year":"2021","unstructured":"Piffoux M, Eriau E, Cassier PA. Autophagy as a therapeutic target in pancreatic cancer. Br J Cancer. 2021;124 (2):333\u201344.","journal-title":"Br J Cancer"},{"key":"4896_CR160","first-page":"2276","volume":"2766","author":"M Moradi","year":"2021","unstructured":"Moradi M, Babaniamansour S, Majidi M, Karkon-Shayan S, Firouzabadi MD, Atarodi A. Langerhans cell histiocytosis of the right scapula. J ISSN. 2021;2766:2276.","journal-title":"J ISSN"},{"issue":"2","key":"4896_CR161","doi-asserted-by":"publisher","first-page":"92","DOI":"10.18502\/aanbt.v6i2.18617","volume":"6","author":"A Asadi","year":"2025","unstructured":"Asadi A, Khaksar E, Valanik S, Ghahramani Y. New methods of preparing calcium nanomaterials as a keystone in biotechnology. Adv Appl NanoBio-Technologies. 2025;6 (2):92\u2013102.","journal-title":"Adv Appl NanoBio-Technologies"},{"issue":"9","key":"4896_CR162","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1080\/15548627.2023.2186112","volume":"19","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang Y, Cao J, Wang Y, Anwar N, Zhang Z, et al. The role of autophagy in bone metabolism and clinical significance. Autophagy. 2023;19 (9):2409\u201327.","journal-title":"Autophagy"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04896-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04896-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04896-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:02:44Z","timestamp":1776751364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04896-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":162,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4896"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04896-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"612"}}